AOBiome
AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that developed strains of Ammonia Oxidizing Bacteria (AOB) to administer live in treatments that address inflammatory conditions.
5
Funding Rounds
$68.7m
Money raised
Overview
AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that developed strains of Ammonia Oxidizing Bacteria (AOB) to administer live in treatments that address inflammatory conditions.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company AOBiome has raised a total of $30m in funding over 5 rounds.
Key Insights:
- AOBiome Funding Round 2017: $30m
- AOBiome Series B Funding Round December 2014: $7.5m
- AOBiome Seed Funding Round March 2013: $630k
- AOBiome Series C Funding Round January 2017: $30m
- AOBiome Venture Funding Round August 2014: $576.5k
AOBiome Funding Round 2017
$30m
AOBiome Seed Funding Round March 2013
$630k
AOBiome Venture Funding Round August 2014
$576.5k
AOBiome Series B Funding Round December 2014
$7.5m
AOBiome Series C Funding Round January 2017
$30m
Industries
AOBiome is active in the following industries: